Stem Cell Treatment for Multiple Sclerosis (AHSCT)

Two very different things are marketed as stem cell treatment for MS. Autologous haematopoietic stem cell transplantation (AHSCT) uses chemotherapy to wipe out the faulty immune system and then returns your own previously collected blood stem cells to rebuild it. Separately, some clinics sell injections of mesenchymal or other stem cells intended to repair nerves.

AHSCT has good trial evidence in highly active relapsing-remitting MS: in a randomised trial, far fewer patients worsened than on standard drugs, and many remain free of relapses and new MRI lesions for years. It does not repair established disability and performs poorly in long-standing progressive MS without inflammation. Mesenchymal and other stem cell injections have not shown reliable benefit in controlled trials and remain experimental.

What Stem Cell Treatment for Multiple Sclerosis (AHSCT) involves

AHSCT has four phases. Mobilisation: cyclophosphamide and daily G-CSF injections push stem cells from the marrow into the blood. Collection: about 10 days later, the cells are harvested from a vein by an apheresis machine over 4 to 6 hours, then frozen. Conditioning: you are admitted to an isolation room and given chemotherapy over 4 to 6 days, most commonly cyclophosphamide with anti-thymocyte globulin (a non-myeloablative regimen) or the more intensive BEAM with ATG. Reinfusion: your cells are thawed and returned through a central line. Blood counts then fall to very low levels for 7 to 12 days, during which you receive antibiotics, antivirals, transfusions and close monitoring until the counts recover (engraftment).

Who is a good candidate for Stem Cell Treatment for Multiple Sclerosis (AHSCT)?

Patient selection determines both the benefit and the risk.

• Relapsing-remitting MS with relapses or new MRI lesions despite one or more high-efficacy disease-modifying drugs
• Age under about 45 to 50
• Disease duration under about 10 years
• EDSS disability score of roughly 6.0 or less, meaning still able to walk
• No major heart, lung, liver or kidney disease, and no active infection

It is usually not the right choice if:

• Secondary or primary progressive MS without recent relapses or MRI activity
• Advanced disability, such as wheelchair dependence
• People hoping to reverse long-established deficits
• Significant organ disease or chronic infection
• Anyone who has not frozen sperm or eggs or considered it, if future fertility matters

الخيارات التقنية

• Non-myeloablative AHSCT (cyclophosphamide and ATG): The regimen used in the principal randomised trial, with lower toxicity.
• BEAM-ATG (intermediate intensity): Used in many European centres; more intensive, with a longer recovery.
• Mesenchymal stem cell infusions: Experimental. A large phase 2 trial did not meet its primary endpoint. Legitimately offered only within clinical trials.
• High-efficacy drugs: Ocrelizumab, ofatumumab, natalizumab, alemtuzumab and cladribine are the alternatives against which AHSCT should be weighed.

ماذا يحدث خلال علاجك

The whole process takes about 4 to 6 weeks, with about 3 weeks of that spent in a protective hospital room. There is no operation. Chemotherapy brings nausea, hair loss, fatigue, mouth soreness and fevers, and MS symptoms can flare temporarily with fever.

الإعداد لرحلتك

Expect a single continuous stay of about 5 to 6 weeks: assessment and mobilisation as an outpatient, then roughly 3 weeks in hospital, then a week nearby before flying. Choose a haematology unit with JACIE or equivalent accreditation that reports its outcomes to the EBMT registry, and agree beforehand with your neurologist and a haematologist at home who will monitor blood counts and infections afterwards.

• Tell the doctor about medication, allergies, pregnancy or breastfeeding, and any history of cold sores, keloid scars or autoimmune disease
• Avoid alcohol, aspirin and anti-inflammatory painkillers for a few days beforehand if your own doctor agrees, to reduce bruising
• Arrive without make-up on the treatment area and avoid sunbeds and strong sun for two weeks before

التعافي والنتائج

Immune recovery takes 6 to 12 months. For the first 3 to 6 months, avoid crowds, sick contacts, gardening soil and undercooked food, and take preventive antivirals and antibiotics as prescribed. Fatigue is prominent for several months. Childhood vaccinations are repeated from about 6 to 12 months. MS drugs are generally stopped. Rehabilitation helps regain conditioning. MRI and neurological review continue each year.

• Back to everyday activity: 3 to 6 months
• When results show: Disease activity is judged on MRI and relapses over 1 to 2 years
• How long they last: Many remain in remission for 5 years or more; not a cure

سياسة السلامة والمخاطر والتنقيح

AHSCT is an intensive treatment with a real, though small, risk of death; this should be stated clearly by any centre.

• Treatment-related death, around 0.3 to 1 percent in experienced centres with careful selection, and higher in older or more disabled patients
• Serious infection while blood counts are low, including sepsis
• Reactivation of viruses such as CMV, EBV and shingles
• Infertility and early menopause
• New autoimmune disorders, particularly thyroid disease and low platelets, in up to about 10 percent
• Temporary worsening of MS symptoms, and brain volume loss in the first year
• Hair loss, which is temporary
• A small long-term risk of secondary cancers

Every written proposal arranged through Clinic-Y states what the clinic covers if a correction is needed. Ask for it before you book, not after.

Cost of Stem Cell Treatment for Multiple Sclerosis (AHSCT) in Türkiye

Clinic-Y does not publish a single price for Stem Cell Treatment for Multiple Sclerosis (AHSCT), because the honest figure depends on your case. What moves it:

• Conditioning regimen and length of the isolation stay
• Apheresis, cell processing and cryostorage
• Transfusions, anti-infective drugs and any intensive care
• Fertility preservation beforehand
• Accommodation for 5 to 6 weeks, plus a carer

Send your photographs or reports and you receive written, all-inclusive proposals from suitable teams, side by side. Reviewing your case is free.

الأسئلة المتكررة